Larson Financial Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.38K Sell
440
-375
-46% -$2.24K ﹤0.01% 2906
2025
Q4
$5.66K Buy
815
+753
+1,215% +$4.95K ﹤0.01% 2404
2025
Q3
$400 Buy
+62
New +$424 ﹤0.01% 3146
2023
Q4
Sell
-310
Closed -$2.55K 1806
2023
Q3
$2.55K Hold
310
﹤0.01% 1313
2023
Q2
$2.48K Hold
310
﹤0.01% 1237
2023
Q1
$2.51K Sell
310
-191
-38% -$1.53K ﹤0.01% 1210
2022
Q4
$3.15K Hold
501
﹤0.01% 1122
2022
Q3
$3K Sell
501
-159
-24% -$1.1K ﹤0.01% 1028
2022
Q2
$6K Buy
660
+159
+32% +$2.22K ﹤0.01% 820
2022
Q1
$11K Buy
+501
New +$12.2K ﹤0.01% 628

Other funds holding BHC

Larson Financial Group's BHC Position: Q1 2026 in Review

Larson Financial Group reduced its Bausch Health (BHC) stake by 46% in Q1 2026, selling an estimated $2.24K and leaving 440 shares worth $2.38K. The position accounts for ﹤0.01% of the portfolio, ranked #2906.

Larson Financial Group first reported a position in BHC in Q1 2022 and has held it in 10 quarters since. The position peaked at $11K in Q1 2022. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Larson Financial Group held 440 shares of Bausch Health worth $2.38K as of Q1 2026.
  • Larson Financial Group sold 375 Bausch Health shares in Q1 2026, an estimated $2.24K.
  • Bausch Health made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2906 holding.
  • Larson Financial Group first reported a position in Bausch Health in Q1 2022 and has held it in 10 quarters since.
  • Larson Financial Group's Bausch Health position peaked at $11K in Q1 2022.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.